BacLite Rapid MRSA Clinical Performance

Solventum US LLC

Overview

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Study Type

OBSERVATIONAL

Conditions

Methicillin Resistance

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects 18 years or older * Subjects willing to document demographic characteristics * Subjects willing to have their nose swabbed * Subjects (or legal representative) willing to sign consent and authorization forms Exclusion Criteria: * Subjects who use Vicks Sinex Nasal spray or other nasal sprays * Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects * Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares * Investigator believes that subject is unsuitable for inclusion.

Locations (9)

Denver Health Medical Center

Denver, Colorado, United States

Atlanta Institute for Medical Research, Inc.

Atlanta, Georgia, United States

Evanston Northwestern Healthcare

Evanston, Illinois, United States

University of Iowa

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.